Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $171.94 USD
Change Today +3.37 / 2.00%
Volume 2.6M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitleKey Developments
R. Norby 48 RelationshipsLead Independent Director, Chairman of Audit & Finance Committee, Member of Nominating & Corporate Governance Committee and Member of Pharmaceutical Compliance & Quality Committee 
Alvin Parven 9 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit & Finance Committee 
John Mollen 9 RelationshipsDirector, Member of Audit & Finance Committee and Member of Compensation Committee 
Christopher Coughlin 47 RelationshipsDirector, Member of Audit & Finance Committee and Member of Pharmaceutical Compliance & Quality Committee 

Compensation Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitle
M. Burns 63 RelationshipsDirector, Chairman of Strategy & Risk Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
John Mollen 9 RelationshipsDirector, Member of Audit & Finance Committee and Member of Compensation Committee
Alvin Parven 9 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit & Finance Committee
ALXN Compensation vs. Industry
696.1K
377.8K
Chief Executive Officer
640.0K
274.6K
Chief Financial Officer
Share price activity for ALEXION PHARMACEUTICALS INC (ALXN)
52 Week Price Performance
ALXN
Industry Average

Nominating Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitleKey Developments
R. Norby 48 RelationshipsLead Independent Director, Chairman of Audit & Finance Committee, Member of Nominating & Corporate Governance Committee and Member of Pharmaceutical Compliance & Quality CommitteeAlexion Pharmaceuticals, Inc. to Appoint Dr. Felix Baker to its Board
05/6/15
Alvin Parven 9 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit & Finance CommitteeAlexion Pharmaceuticals, Inc. Announces Retirement of William Keller from Board
03/26/15
Ann Veneman J.D. 51 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee, Member of Pharmaceutical Compliance & Quality Committee and Member of Strategy & Risk CommitteeAlexion Pharmaceuticals, Inc. Announces Board Changes, Effective from January 1, 2015
11/10/14
M. Burns 63 RelationshipsDirector, Chairman of Strategy & Risk Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance CommitteeAlexion Pharmaceuticals, Inc. Announces Executive Appointments
10/9/14

Corporate Governance Committee* - alexion pharmaceuticals inc (ALXN)

Name (Connections)Board RelationshipsTitle
M. Burns 63 RelationshipsDirector, Chairman of Strategy & Risk Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
R. Norby 48 RelationshipsDirector, Member of Audit & Finance Committee and Member of Compensation Committee
Alvin Parven 9 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit & Finance Committee
Ann Veneman J.D. 51 Relationships--
ALXN and Competitor
Insiders vs. External
Board
20%
80%
Alexion Pharmaceuticals, Inc.
14%
86%
Pharmacyclics Inc.
15%
85%
United Therapeutics Corporation
10%
90%
Sigma-Aldrich Corporation
15%
85%
Symrise AG
17%
83%
Dr. Reddy's Laboratories Ltd.
Insiders
External Board Members

Finance Committee* - alexion pharmaceuticals inc (ALXN)

Name(Connections)Board RelationshipsTitle
Christopher Coughlin 47 RelationshipsDirector, Member of Audit & Finance Committee and Member of Pharmaceutical Compliance & Quality Committee
John Mollen 9 RelationshipsDirector, Member of Audit & Finance Committee and Member of Compensation Committee
R. Norby 48 RelationshipsLead Independent Director, Chairman of Audit & Finance Committee, Member of Nominating & Corporate Governance Committee and Member of Pharmaceutical Compliance & Quality Committee
Alvin Parven 9 RelationshipsIndependent Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit & Finance Committee
Debt To Total Capitalization4.4x
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $171.94 USD +3.37

ALXN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,643 INR +23.45
Pharmacyclics Inc $261.25 USD +1.70
Sigma-Aldrich Corp $139.08 USD -0.01
Symrise AG €57.87 EUR -0.264
United Therapeutics Corp $183.69 USD +1.08
View Industry Companies
 

Industry Analysis

ALXN

Industry Average

Valuation ALXN Industry Range
Price/Earnings 58.9x
Price/Sales 15.1x
Price/Book 9.8x
Price/Cash Flow 58.3x
TEV/Sales 14.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.